Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
US OptionsDetailed Quotes
PCVX250516C30000
- 2.70
- 0.000.00%
15min DelayClose May 9 16:00 ET
0.00High0.00Low
2.70Open2.70Pre Close0 Volume9 Open Interest30.00Strike Price0.00Turnover143.80%IV4.94%PremiumMay 16, 2025Expiry Date1.16Intrinsic Value100Multiplier4DDays to Expiry1.54Extrinsic Value100Contract SizeAmericanOptions Type0.6262Delta0.0767Gamma12.10Leverage Ratio-0.2256Theta0.0021Rho7.58Eff Leverage0.0130Vega
Vaxcyte Newsroom
Vaxcyte, Inc. Reports Q1 2025 Financial Results
TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $85
Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $90
Vaxcyte Shares Are Trading Higher After the Company Reported Better-than-expected Q1 EPS Results.
Optimistic Outlook for Vaxcyte's Vaccines Drives Buy Rating
Vaxcyte | 10-Q: Q1 2025 Earnings Report
Vaxcyte | 8-K: Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
Vaxcyte 1Q Loss/Shr $1.04 >PCVX
Express News | Vaxcyte Q1 Operating Expenses USD 180.793 Million
Express News | Vaxcyte Q1 Cash & Investments USD 2,950.762 Million
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
Vinay Prasad to Head FDA Division Regulating Vaccines
Vaxcyte Appoints Dr. Olivier Brandicourt to Board
Express News | Vaxcyte Appoints DR. Olivier Brandicourt to Board of Directors
Is Vaxcyte, Inc. (PCVX) the Best Oversold NASDAQ Stock to Buy Right Now?
Cantor Fitzgerald Initiates Vaxcyte(PCVX.US) With Buy Rating
Cantor Fitzgerald Initiates Coverage On Vaxcyte With Overweight Rating
TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $135
Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots.
Express News | Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
